X4 Pharmaceuticals, Inc. — Form D/A
X4 Pharmaceuticals, Inc. of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2018-09-21. The offering totals $35.0M, of which $35.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-09-21
- Form: D/A
- Accession: 0001632304-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $35.0M
- Minimum investment: $50K
- Investors: 214
- Date of first sale: 2017-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-298854
Issuer
- Name: X4 Pharmaceuticals, Inc.
- CIK: 0001632304
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 955 Massachusetts Avenue, Cambridge, MA, 02139
- Phone: 339-203-1076
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Isaac Blech | Director | Jupiter, FL |
| Michael Gilman | Director | Waltham, MA |
| Paula Ragan | Director | Boston, MA |
| Alan E Walts | Director | Cambridge, MA |
| Michael Wyzga | Director | Boston, MA |
| Adam Mostafa | Executive Officer | Toronto, A6 |
| Paula Ragan | Executive Officer | Boston, MA |
| Alan E Walts | Executive Officer | Cambridge, MA |
| Alan Walts | Director | Cambridge, MA |
| John Cheney | Executive Officer | Denver, CO |
| Alison Lawton | Executive Officer | Boston, MA |
| Nancy Lurker | Director | WATERTOWN, MA |
| Sudha Parasuraman | Executive Officer | Cambridge, MA |
| Andrea K Franz | Executive Officer | Cambridge, MA |
| John Celebi | Executive Officer | Cambrdge, MA |
| Robert Arbeit | Executive Officer | Cambridge, MA |
Other filings by this issuer (3)
More